HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis
NCT03934736
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
119
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease on Hemodialysis (Diagnosis)
Interventions
DRUG:
HEPLISAV-B®
Sponsor
Dynavax Technologies Corporation